Patent · US Active

N-[(Pyrimidinylamino)propanyl]-and N-[(Pyridinylamino)-propanyl]arylcarboxamides

US10710984B2 · kind B2 · utility

0Cited by

2References

8Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Doris Riether · Biberach an der Riß, DE
Marco Ferrara · San Donato Milanese, IT
Niklas Heine · Eberhardzell, DE
Uta Friederike Lessel · Maselheim, DE
Janet Rachel Nicholson · Oberhofen, DE
Anton Pekcec · Munich, DE
Stefan Scheuerer · Warthausen, DE

Key dates

Filing date	Apr 7, 2017
Grant date	Jul 14, 2020
Priority date	—
Expiry date	Apr 7, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel N-[(Pyrimidinylamino)propanyl]- and N-[(Pyridinylamino)propanyl]arylcarboxamide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment or prevention of conditions having an association with the orexin sub-type 1 receptor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.